Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells
Cr. Hauck et al., Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells, CANCER RES, 61(19), 2001, pp. 7079-7090
Elevated focal adhesion kinase (FAK) expression in human tumor cells has be
en correlated with an increased cell invasion potential. In cell culture, s
tudies with FAK-null fibroblasts have shown that FAK function is required f
or cell migration. To determine the role of elevated FAK expression in faci
litating epidermal growth factor (EGF)-stimulated human adenocarcinoma (A54
9) cell motility, antisense oligonucleotides were used to reduce FAK protei
n expression >75%. Treatment of A549 cells with FAK antisense (ISIS 15421)
but not a mismatched control (ISIS 17636) oligonucleotide resulted in reduc
ed EGF-stimulated p130(Cas)-Src complex formation, e-Jun NH2-terminal kinas
e (JNK) activation, directed cell motility, and serum-stimulated cell invas
ion through Matrigel. Because residual FAK protein in ISIS 15421-treated A5
49 cells was highly phosphorylated at the Tyr-397/Src homology (SH)2 bindin
g site, expression of the FAK COOH-terminal domain (FRNK) was also used as
an inhibitor of FAK function. Adenoviral-mediated infection and expression
of FRNK promoted FAK dephosphorylation at Tyr-397, resulted in reduced EGF-
stimulated JNK as well as extracellular-regulated kinase 2 (ERK2) kinase ac
tivation, inhibited matrix metalloproteinase-9 (MMP-9) secretion, and poten
tly blocked both random and EGF-stimulated A549 cell motility. Equivalent e
xpression of a FRNK (S-1034) point-mutant that did not promote FAK dephosph
orylation also did not affect EGF-stimulated signaling or cell motility. Do
se-dependent reduction in EGF-stimulated A549 motility was observed with th
e PD98059 MEK1 inhibitor and the batimastat (BB-94) inhibitor of MMP activi
ty, but not with the SB203580 inhibitor of P38 kinase. Finally, comparisons
between normal, FAK-null, and FAK-reconstituted fibroblasts revealed that
FAK enhanced EGF-stimulated JNK and ERK2 kinase activation that was require
d for cell motility. These data indicate that FAK functions as an important
signaling platform to coordinate EGF-stimulated cell migration in human tu
mor cells and support a role for inhibitors of FAK expression or activity i
n the control of neoplastic cell invasion.